Hartter E, Svoboda T, Ludvik B, Schuller M, Lell B, Kuenburg E, et al
It can be so disheartening to be getting better from one ailment only to discover that you have another issue to address
Notably, SURMOUNT-2 specifically evaluated tirzepatide in individuals with type 2 diabetes, demonstrating superiority over both GLP-1 monotherapy and insulin-based regimens
This evidence supports the cardiovascular safety and potential benefit of semaglutide in this population
A bottle of pills is shelf-stable and easier to transport in a carry-on bag
Sanity-checking total yield against per-draw amount catches gross errors if your arithmetic implies only three or four draws from a 10 mg vial, you have almost certainly mislabeled mg as mcg somewhere, a thousand-fold error that the per-unit figure alone would not reveal